1019B |
Carbrital Profile, Blood |
1019SP |
Carbrital Profile, Serum/Plasma |
1876FL |
Drug Screen - Expanded, Fluid |
2041U |
Flunitrazepam and Metabolites, Urine |
8030B |
Drug Facilitated Crime Panel, Blood (Forensic) |
8030SP |
Drug Facilitated Crime Panel, Serum/Plasma (Forensic) |
8030U |
Drug Facilitated Crime Panel, Urine (Forensic) |
8098B |
Drug Screen (GC/MS), Blood |
8098SP |
Drug Screen (GC/MS), Serum/Plasma |
8098U |
Drug Screen (GC/MS), Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9326B |
Gamma-Hydroxybutyric Acid Screen, Blood |
9326FL |
Gamma-Hydroxybutyric Acid Screen, Fluid |
9326SP |
Gamma-Hydroxybutyric Acid Screen, Serum/Plasma |
9326U |
Gamma-Hydroxybutyric Acid Screen, Urine |
9329B |
Benzodiazepines Panel, Blood |
9329FL |
Benzodiazepines Panel, Fluid |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9329SP |
Benzodiazepines Panel, Serum/Plasma |
9329TI |
Benzodiazepines Panel, Tissue |
9329U |
Benzodiazepines Panel, Urine |
9341B |
Flunitrazepam and Metabolites Screen, Blood |
9341SP |
Flunitrazepam and Metabolites Screen, Serum/Plasma |
9341TI |
Flunitrazepam and Metabolites Screen, Tissue |
9341U |
Flunitrazepam and Metabolites Screen, Urine |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |